Sarah Rachel Pollock

USPTO Granted Patents = 19 (Patent Applications = 11)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 8.0

ph-index = 6

Forward Citations = 300(Granted Patents)

Company Filing History:

16 out of 60

Compugen Ltd. Corporation

Years Active: 2003-2020

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10597671 - Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield, biomass, oil content and/or growth rate (2020-03-24),

2. 9487795 - Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield, biomass, oil content and/or growth rate (2016-11-08),

3. 9347952 - Soluble VEGFR-1 variants for diagnosis of preeclampsia (2016-05-24),

4. 8937220 - Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield, biomass, vigor and/or growth rate of a plant (2015-01-20),

5. 7939634 - Polynucleotides encoding polypeptides and methods using same (2011-05-10),

6. 7906635 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer (2011-03-15),

7. 7842459 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis (2010-11-29),

8. 7741433 - Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof (2010-06-22),

9. 7714100 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease (2010-05-11),

10. 7667001 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer (2010-02-23),

11. 7601692 - MCP-1 splice variants and methods of using same (2009-10-13),

12. 7569662 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer (2009-08-04),

13. 7553948 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer (2009-06-30),

14. 7528243 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer (2009-05-05),

15. 7488813 - Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof (2009-02-10),

Title: Innovations of Sarah Rachel Pollock in Plant Biotechnology

Introduction

Sarah Rachel Pollock, located in Tel Aviv, Israel, is a prominent inventor in the field of plant biotechnology. With a remarkable portfolio of 19 patents, she has contributed significantly to enhancing plant yields and resilience through innovative biotechnological methods.

Latest Patents

Her latest patents focus on isolated polynucleotides and polypeptides, aimed at increasing plant yield, biomass, oil content, and growth rate. The patents provide isolated polynucleotides comprising nucleic acid sequences encoding polypeptides that exhibit at least 94% sequence identity to a specific sequence. These innovations also include nucleic acid constructs and methods for improving various plant qualities such as vigor, abiotic stress tolerance, and nitrogen use efficiency.

Career Highlights

Sarah has worked with notable companies in the biotech sector, including Compugen Ltd. and Evogene Ltd. Her experiences at these institutions have allowed her to develop her research and patent portfolio significantly.

Collaborations

Throughout her career, Sarah has collaborated with accomplished professionals in her field. Notable coworkers include Osnat Sella-Tavor and Zurit Levine, with whom she has worked to advance research and innovation in plant biotechnology.

Conclusion

Sarah Rachel Pollock's contributions to the field of plant biotechnology are characterized by her innovative patents and collaborations with industry professionals. Her advancements in isolating polynucleotides and polypeptides showcase the potential for significantly enhancing agricultural productivity and resilience in the face of environmental challenges.

This text is generated by artificial intelligence and may not be accurate.